Gainesborough Investments

Gainesborough Investments is a private investment vehicle, widely reported to be associated with the Al-Thani family of Qatar. The firm is primarily known in the life sciences sector for its significant equity stakes in UK-based healthcare companies, most notably Circassia Pharmaceuticals (now NIOX Group) and Vectura. As an investment entity rather than a drug developer, it does not maintain an internal R&D pipeline or therapeutic programs. Instead, it provides capital and strategic backing to established and emerging biotech and specialty pharma entities. Its investment strategy has historically focused on respiratory health and medical technology through its major holdings. The company often acts as a cornerstone investor, providing financial stability for its portfolio companies to pursue clinical development and commercialization.